March 2022

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 5000 plus people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.

On 4th March 1948 Pharmacy Act was enacted in the Independent India to safeguard public health. This public welfare enactment had three main purposes:-
(i) Only duly qualified persons in the field of Pharmacy shall enter the profession of pharmacy to ensure precise and accurate dispensing of modern allopathic medicines for ensuring safe and effective therapy;

AstraZeneca’s Rare Disease group, has closed an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), an underdiagnosed, systemic condition that leads to progressive heart failure and high rate of fatality within four years from diagnosis.1,2

Alexion has been granted an exclusive worldwide licence to develop, manufacture and commercialise NI006.

The Central Government Health Scheme was started in 1954 with the objective of providing comprehensive medical care to the Central Government employees, both serving and pensioners and their dependent family members. The scheme is also providing service to members and former members of parliament, judges of Supreme Court and High Court, freedom fighters, former Governors and former Vice-Presidents of India.

Post : Pharmacist (Allopathy)

The institute was established as Regional Research Institute (Ayurveda) on February 19, 1981 as peripheral unit under the Central Council For Research in Ayurveda and Siddha (CCRAS) and started functioning along with the facilities of OPD, IPD and Mobile Clinical Research Unit (MCRU) Pathology and Bio chemistry Laboratory at Lucknow. The institute was upgraded and renamed as Central Research Institute (Ayurveda) on February 1997 by merging various units.

Applications are invited for the following post on contractual basis.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state of art of R&D wing of the Tata Memorial Centre.

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy. TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

The Central University of Rajasthan (CURAJ) has been established by an Act of Parliament (Act No. 25 of 2009) as a new Central University, and is fully funded by the Government of India. The President of India, His Excellency Shri Ram Nath Kovind, is the Visitor of the CURAJ. Prof. Anand Bhalerao is the Vice Chancellor of the University. CURAJ is located in Ajmer district of Rajasthan.